29.03.22 | COVID – 19 Vaccination Update – Day 437

ad
Ministry of health and family
Ministry of health and family

India’s COVID-19 vaccination coverage has crossed 183.49 Crore (1,83,49,72,675) today. More than 22 lakh (22,89,185Vaccine Doses have been administered till 7 pm today. More than 1.35 Crore (1,35,00,862) vaccine doses have been administered to 12-14 years age group so far. More than 2.27 Crore (2,27,18,612) Precaution Doses for the identified categories of beneficiaries (HCWs, FLWs and Over 60 years) for COVID vaccination have been administered so far. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs 1st Dose 10403526
2nd Dose 9997254
Precaution Dose 4433431
FLWs 1st Dose 18412900
2nd Dose 17503787
Precaution Dose 6817215
Age Group 12-14 years 1st Dose 13500862
Age Group 15-18 years 1st Dose 56913111
2nd Dose 37439773
Age Group 18-44 years 1st Dose 554368948
2nd Dose 464189872
Age Group 45-59 years 1st Dose 202705853
2nd Dose 184923341
Over 60 years 1st Dose 126707548
2nd Dose 115187288
Precaution Dose 11467966
Cumulative 1st dose administered 983012748
Cumulative 2nd dose administered 829241315
Precaution Dose 22718612
Total 1834972675

 

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 28th March, 2022 (437th Day)
HCWs 1st Dose 39
2nd Dose 669
Precaution Dose 9357
FLWs 1st Dose 74
2nd Dose 1720
Precaution Dose 17634
Age Group 12-14 years 1st Dose 1114215
Age Group 15-18 years 1st Dose 78067
2nd Dose 186696
Age Group 18-44 years 1st Dose 60931
2nd Dose 503860
Age Group 45-59 years 1st Dose 9052
2nd Dose 117401
Over 60 years 1st Dose 6266
2nd Dose 72638
Precaution Dose 110566
Cumulative 1st dose administered 1268644
Cumulative 2nd dose administered 882984
Precaution Dose 137557
Total 2289185

 

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.

Be the first to comment

Leave a Reply